Emerging & Hybrid IPAI & Future
Regenerative Medicine (iPS Cells)
PopularityOverview
Japan's regenerative medicine research based on Professor Shinya Yamanaka's iPS cell technology. Since the 2012 Nobel Prize, clinical applications have steadily advanced. Japan leads the world in practical iPS cell treatments for retinal diseases, heart disease, and Parkinson's disease.
Note: This content was generated as an idea by our editorial AI from public sources.
Metadata
Category:Emerging & Hybrid IP
Subcategory:AI & Future
Location:Kyoto (Kyoto University)
Time Period:2006-present
Influence:Global
Tags
iPS CellsRegenerative MedicineNobel Prize
Explore by Tag
Contemporary IPs
2006Regenerative Medicine (iPS Cells)Emerging & Hybrid IP
Recent News
Loading...
📱 Share on Social
Discovered: Regenerative Medicine (iPS Cells)! Japan's regenerative medicine research based on Professor Shinya Yamanaka's iPS … #iPSCells #RegenerativeMedicine #NobelPrize #JAPANIPCATALYST #JapanCulture
